Bepridil is a calcium channel blocker historically indicated for the treatment of angina pectoris, functioning by inhibiting L-type calcium channels in vascular smooth muscle. This category contains a… Read more
Bepridil is a calcium channel blocker historically indicated for the treatment of angina pectoris, functioning by inhibiting L-type calcium channels in vascular smooth muscle. This category contains a comprehensive selection of reference standards for the parent drug, alongside its related pharmacopeial and non-pharmacopeial impurities and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories to conduct rigorous analytical testing and quality control of the active pharmaceutical ingredient. Chemists utilize these reference materials for impurity profiling, method validation, and to ensure accurate quantification during stability studies or drug substance analysis. By providing high-quality standards, this collection supports the development and maintenance of robust analytical procedures necessary for monitoring Bepridil and identifying degradants or synthetic byproducts in complex pharmaceutical matrices.